Health and Fitness Health and Fitness
Wed, July 14, 2010
[ 01:00 PM ] - Market Wire
SurModics to Webcast Third Quarter Fiscal Year 2010 Earnings Conference Call July 28
[ 01:00 PM ] - Market Wire
Cytokinetics to Present Phase I Data Relating to .. International Congress on Neuromuscular Diseases
[ 01:00 PM ] - Market Wire
Peregrine Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2010 Financial Results
[ 11:54 AM ] - Market Wire
USANA Schedules Second Quarter Earnings Release and Conference Call
[ 11:00 AM ] - Market Wire
Edwards Lifesciences to Host Earnings Conference Call on July 21, 2010
[ 08:54 AM ] - Market Wire
Big Stick Media Corporation Announces Special Sha .. With Amalgamation to Effect Delisting and Privat
[ 08:29 AM ] - Market Wire
Mesa Uranium Signs Letter of Intent on the Holbrook Potash Project
[ 08:15 AM ] - Market Wire
Aeterna Zentaris Announces Perifosine Has Receive .. ug Designation for the Treatment of Neuroblastoma
[ 07:39 AM ] - Market Wire
EverdowCRM Inc. (ZMGD) Publishes the Company Financials
[ 06:44 AM ] - Market Wire
Four Big Pharmas Bet Big on Intellect Neurosciences' Platform to Treat Alzheimer's Disease
[ 06:30 AM ] - Market Wire
Merit Medical Systems Announces Earnings Release .. Information for the Second Quarter Ended June 30
[ 06:24 AM ] - Market Wire
Radient Pharmaceuticals Launches New Corporate Video and Website
[ 06:15 AM ] - Market Wire
Miles de jvenes "HROES" han colaborado con United .. lth Group en la lucha contra la obesidad infantil
[ 05:01 AM ] - Market Wire
Molecular Insight Pharmaceuticals' Zemiva Phase 2 .. in Journal of the American College of Cardiology
[ 05:00 AM ] - Market Wire
Peregrine Initiates Second Randomized Phase IIb L .. In-Class PS-Targeting Monoclonal Antibody Bavitux
[ 03:40 AM ] - Market Wire
Trinity Biotech plc to Announce Second Quarter 2010 Financial Results
[ 03:00 AM ] - Market Wire
Illumina to Announce Second Quarter 2010 Financial Results on Tuesday, July 27, 2010
[ 01:22 AM ] - Market Wire
Oncura(TM) Announces Exclusive Supply and Resale Agreement With Theragenics Corporation
Tue, July 13, 2010
[ 09:01 PM ] - Market Wire
Emergent BioSolutions Awarded HHS Contract Valued .. to Develop Large-Scale Manufacturing for BioThrax
[ 03:30 PM ] - Market Wire
The Egleston Law Firm Announces Investigation of Skilled Healthcare Group, Inc.
[ 03:05 PM ] - Market Wire
Prestige Brands Holdings, Inc. to Release Fiscal 2011 First Quarter Earnings on August 5th
[ 02:30 PM ] - Market Wire
Gilead Sciences to Release Second Quarter 2010 Financial Results on Tuesday, July 20, 2010
[ 02:01 PM ] - Market Wire
PPD and Lovelace Biomedical and Environmental Res .. llaboration for Laboratory, Preclinical and Clini
[ 01:30 PM ] - Market Wire
NuVasive Announces Conference Call and Webcast of Second Quarter 2010 Results
[ 01:01 PM ] - Market Wire
Cubist Announces Objectives Met in Phase 2 Safety Study of CUBICIN in Prosthetic Joint Infections
[ 01:01 PM ] - Market Wire
Vertex Pharmaceuticals Appoints Wayne J. Riley, M.D., to its Board of Directors
[ 01:00 PM ] - Market Wire
Anika Therapeutics Announces Date of Second-Quarter 2010 Financial Results Conference Call
[ 01:00 PM ] - Market Wire
WellTek Subsidiary Unveils Platform for Integrating Network Marketing With Social Network
[ 12:27 PM ] - Market Wire
Molina Healthcare Announces Second Quarter 2010 Earnings Release and Conference Call Date
[ 11:44 AM ] - Market Wire
KCI stimuleert mogelijkheden voor onderzoek en on .. centrum voor geavanceerd onderzoek en technologie

KCI stimuleert mogelijkheden voor onderzoek en ontwikkeling met lancering centrum voor geavanceerd onderzoek en technologie


Published on 2010-07-13 11:50:41 - Market Wire
  Print publication without navigation


SAN ANTONIO--([ BUSINESS WIRE ])--Kinetic Concepts, Inc. (NYSE: KCI) maakt vandaag bekend het ART-centrum te hebben opgezet. De afkorting staat voor Advanced Research and Technology. Het centrum zal richting geven aan de inspanningen van het bedrijf om revolutionaire nieuwe wondgenezingen te ontwikkelen. Ook is het centrum bedoeld voor regeneratieve geneeskunde en technologie voor beademingsapparaten. Het ART-centrum van KCI zal dienen als een innovatiecentrum dat opkomende medische behandelingen en technologien onderzoekt ter bevordering van productontwikkeling.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.

Contributing Sources